8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

Metabolic and genetic screening of electromagnetic hypersensitive subjects as a feasible tool for diagnostics and intervention.

Bioeffects Seen

De Luca C, Chung Sheun Thai J, Raskovic D, Cesareo E, Caccamo D, Trukhanov A, Korkina L. · 2014

View Original Abstract
Share:

People with electromagnetic hypersensitivity show measurable blood chemistry changes and genetic variants that increase their sensitivity risk by nearly 10-fold.

Plain English Summary

Summary written for general audiences

Italian researchers analyzed blood samples from 153 people with electromagnetic hypersensitivity (EHS) and found distinctive metabolic changes including increased oxidative stress and specific genetic variations. These blood markers could potentially serve as diagnostic tools to identify EHS as a legitimate medical condition.

Why This Matters

This research represents a significant step toward legitimizing electromagnetic hypersensitivity as a diagnosable medical condition rather than dismissing it as psychological. The science demonstrates that people with EHS have measurable, objective biological differences - including compromised antioxidant systems and genetic variants affecting detoxification pathways. What makes this particularly compelling is the identification of specific genetic markers that increase EHS risk nearly 10-fold, suggesting some individuals may be biologically predisposed to electromagnetic sensitivity. The reality is that while the wireless industry continues to dismiss EHS concerns, studies like this provide concrete evidence that sensitive individuals experience real physiological changes. You don't have to accept feeling unwell around technology - understanding your genetic susceptibility could help guide protective strategies.

Exposure Information

Specific exposure levels were not quantified in this study.

Study Details

The purpose of this study is to observe Metabolic and Genetic Screening of Electromagnetic Hypersensitive Subjects as a Feasible Tool for Diagnostics and Intervention

we tested a panel of 12 metabolic blood redox-related parameters and of selected drug-metabolizing-e...

We first described comparable-though milder-metabolic pro-oxidant/proinflammatory alterations in EHS...

Altogether, results on MCS and EHS strengthen our proposal to adopt this blood metabolic/genetic biomarkers' panel as suitable diagnostic tool for SRI.

Cite This Study
De Luca C, Chung Sheun Thai J, Raskovic D, Cesareo E, Caccamo D, Trukhanov A, Korkina L. (2014). Metabolic and genetic screening of electromagnetic hypersensitive subjects as a feasible tool for diagnostics and intervention. Mediators Inflamm. 2014;2014:924184. doi: 10.1155/2014/924184. Epub 2014 Apr 9.
Show BibTeX
@article{c_2014_metabolic_and_genetic_screening_1628,
  author = {De Luca C and Chung Sheun Thai J and Raskovic D and Cesareo E and Caccamo D and Trukhanov A and Korkina L.},
  title = {Metabolic and genetic screening of electromagnetic hypersensitive subjects as a feasible tool for diagnostics and intervention.},
  year = {2014},
  
  url = {https://www.hindawi.com/journals/mi/2014/924184/},
}

Quick Questions About This Study

Italian researchers found distinctive blood markers in 153 electromagnetic hypersensitive people, including increased oxidative stress and specific genetic variations. These metabolic changes could serve as diagnostic tools to identify EHS as a legitimate medical condition requiring clinical recognition.
The 2014 study identified specific gene variants that increase EHS risk nearly 10-fold. People with null GSTT1 and GSTM1 gene variants showed 9.7 times higher risk of developing electromagnetic hypersensitivity compared to those with normal gene function.
Blood analysis of 153 EHS patients revealed increased oxidative stress markers, particularly elevated coenzyme Q10 oxidation ratios. These pro-oxidant and inflammatory changes in blood chemistry distinguish electromagnetically sensitive people from healthy controls through measurable metabolic alterations.
Researchers found significantly altered distribution of CYP2C19 gene variants in electromagnetic hypersensitive subjects compared to controls. This cytochrome P450 enzyme variation may influence how the body processes environmental toxins and responds to electromagnetic field exposure.
The study proposes using blood metabolic and genetic biomarker panels as diagnostic tools for electromagnetic hypersensitivity. Distinctive patterns of oxidative stress markers and genetic variants could provide objective medical evidence for this controversial condition.